| Filing Date | T Date | Ticker | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/16/25 18:52 | 5/14/25 | ITOS | Health | BioPrd | Biological Products, (No Diag | Ecor1 Capital, LLC | CA | T | P.m | 38,686 | 7.80 | 0 | 4,959 | 87 | 10,689 | I | |||||||||||||||
| 11/19/24 19:59 | 11/19/24 | ITOS | Health | BioPrd | Biological Products, (No Diag | Gall Matthew | MA | O | CFO | P | 39 | 7.73 | 0 | 5 | 8 | 65 | D | ||||||||||||||
| 10/12/23 17:09 | 10/12/23 | ITOS | Health | BioPrd | Biological Products, (No Diag | Gall Matthew | MA | O | CFO | P | 42 | 8.37 | 0 | 5 | 35 | 19 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |